Flossbach Von Storch Ag Bio N Tech Se Transaction History
Flossbach Von Storch Ag
- $23.9 Billion
- Q2 2025
A detailed history of Flossbach Von Storch Ag transactions in Bio N Tech Se stock. As of the latest transaction made, Flossbach Von Storch Ag holds 4,230,098 shares of BNTX stock, worth $446 Million. This represents 1.88% of its overall portfolio holdings.
Number of Shares
4,230,098
Previous 4,259,631
0.69%
Holding current value
$446 Million
Previous $388 Million
16.11%
% of portfolio
1.88%
Previous 1.71%
Shares
14 transactions
Others Institutions Holding BNTX
# of Institutions
320Shares Held
40.9MCall Options Held
1.38MPut Options Held
1.52M-
Baillie Gifford & CO8.04MShares$848 Million0.67% of portfolio
-
Primecap Management CO Pasadena, CA4MShares$422 Million0.35% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.6MShares$380 Million0.24% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$200 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.51MShares$159 Million0.79% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $25.6B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...